If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

Shares of UnitedHealth and Nike are trading higher Wednesday afternoon, lifting the Dow Jones Industrial Average into positive territory. The Dow was most recently trading 407 points, or 0.9%, higher, ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Merck & Co., Inc. recently reported robust earnings, yet the market response was lukewarm. Investors overlooked several positive aspects beneath the surface. Unusual expenses, totaling US$4.2 billion, ...

The new North Chicago facility, slated to open in 2027, will boost domestic production of key drug ingredients for immunology ...

Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...

Bringing some payment activities in-house while outsourcing others can help sponsors optimize clinical trial efficiency, ...